Welcome!

News Feed Item

B Cell Study May Lead to Treatment Options for Progressive MS

MS Society of Canada and MS Scientific Research Foundation announce $3.6 million grant to understanding B cells for future MS therapies

TORONTO, ONTARIO -- (Marketwired) -- 02/18/14 -- The Multiple Sclerosis Society of Canada and the Multiple Sclerosis Scientific Research Foundation announced a $3.6 million grant to investigate the role of the B cell, a type of white blood cell of the immune system, in contributing to the development and propagation of multiple sclerosis. With collaboration between McGill University, Universite de Montreal and University of Toronto, world-leading MS experts Drs. Amit Bar-Or, Alexandre Prat and Jennifer Gommerman will engage in a unique interdisciplinary approach to identify and explain the role of B cells in MS.

To date, modern scientific understanding has considered MS to be a disease controlled by the T cell, another type of white blood cell. Research has shown that in MS, T cells mistakenly recognize and attack myelin, the protective layer of fat covering nerves in the central nervous system, exposing them to damage. Research in T cells has led to the development of therapies that aim to control or block the effects of harmful T cells.

However, a surprising discovery in emerging studies has revealed that therapies targeting B cells led to dramatic improvements in people living with MS. Moreover, B cells have recently been found in areas of the brain associated with progressive MS, which is a debilitating form of MS that currently has no treatments. These recent studies have led scientists to believe that B cells, which were previously overlooked in MS, are significant contributors to the disease.

"Based on the encouraging clinical trial results of B cell depletion in people with relapsing-remitting MS, the question is no longer whether B cells are important contributors to MS, but how they contribute," said Dr. Amit Bar-Or, clinician and scientist at the Montreal Neurological Institute at McGill University, and one of the study's lead investigators. "Members of our team have recently discovered that different types of human B cells exist. Some B cells promote inflammation, while others are actually able to limit inflammation. This collaborative study will allow us to address important emerging issues relevant to understanding and better treating MS, especially progressive MS."

"This funding provides a unique occasion to pool scientific resources and expertise from three major MS research centres in Canada to study the influence of B cells in the development of MS," said Dr. Alexandre Prat, neurologist and researcher at the Centre hospitalier de l'Universite de Montreal and professor at the Faculty of Medicine of Universite de Montreal. "It is truly an exciting moment for us, and for the MS community in general."

Drs. Bar-Or, Prat and Gommerman will collaborate to uncover fundamental knowledge about how B cells influence the course of MS. This information will point to clues about the cause of MS, while enabling them to explore the potential of B cell-targeted treatments for people living with all forms of MS.

"Our multi-centre team provides a large range of expertise, from clinical experience to extensive knowledge in immunology. Our collaborative research will accomplish our goal to learn more about B cells in MS, so that one day we could develop therapies for progressive forms of the disease," said Dr. Jennifer Gommerman, scientist and associate professor at the Faculty of Medicine of University of Toronto.

"As Canada has the highest rate of MS in the world, Canadian researchers have a special interest in finding new ways to think about the cause of MS and improve therapies for Canadians living with the disease," said Dr. Karen Lee, vice-president of research, MS Society of Canada. "We are excited that this research team is breaking new ground in the field of MS research that will further our knowledge about the complexity of MS. We believe that an end to MS is achievable, and this B cell study will bring us closer to finding the answers we need and ending MS."

"I think that finding the cause and cure for MS involves innovative thinking and ideas as well as working together to ultimately end this disease," said Andrea Butcher-Milne, who was diagnosed with MS in 1997. "It gives me comfort that researchers in our country are doing their best to realize the promise of a brighter future for people with MS."

This study has been selected by the Canadian Institutes of Health Research to be presented at this month's Cafe Scientifique held on February 18 in Toronto. Cafe Scientifique is an interactive series of presentations that allow scientists to share their research advances to the general public. For more details, visit the Cafe Scientifique website.

About multiple sclerosis and the MS Society of Canada

Canada has the highest rate of multiple sclerosis in the world. MS is a chronic, often disabling disease of the central nervous system comprising the brain, spinal cord and optic nerve. It is the most common neurological disease of young adults in Canada. Most people with MS are diagnosed between the ages of 15 and 40, and the unpredictable effects of MS last for the rest of their lives. The MS Society provides services to people with MS and their families and funds research to find the cause and cure for this disease. Please visit mssociety.ca or call 1-800-268-7582 to make a donation or for more information.

About the Multiple Sclerosis Scientific Research Foundation

The Multiple Sclerosis Scientific Research Foundation funds large, innovative, multi-centre collaborative studies that will lead to major advances in the field of multiple sclerosis. A unique Canadian resource, the Foundation's main funding source is the MS Society of Canada.

The Neuro

The Montreal Neurological Institute and Hospital - The Neuro, is a unique academic medical centre dedicated to neuroscience. Founded in 1934 by the renowned Dr. Wilder Penfield, The Neuro is recognized internationally for integrating research, compassionate patient care and advanced training, all key to advances in science and medicine. The Neuro is a research and teaching institute of McGill University and forms the basis for the Neuroscience Mission of the McGill University Health Centre. Neuro researchers are world leaders in cellular and molecular neuroscience, brain imaging, cognitive neuroscience and the study and treatment of epilepsy, multiple sclerosis and neuromuscular disorders. For more information, visit theneuro.com.

About the Centre hospitalier de l'Universite de Montreal

The Centre hospitalier de l'Universite de Montreal (CHUM) first and foremost provides highly specialized healthcare in all medical specialties to a regional and supra-regional adult clientele. It is the main centre for development and knowledge transfer through its integrated activities in healthcare, teaching, research, assessment of technologies and treatment methods, as well as quality, the promotion of health and the patient experience. As of 2016, the CHUM will offer an improved hospital experience in its new downtown Montreal facilities. The CHUM is an active member of the Reseau universitaire integre de sante (RUIS) de l'Universite de Montreal. chumontreal.qc.ca

About the University of Toronto Faculty of Medicine

The University of Toronto Faculty of Medicine is at the heart of one of the great biomedical research, education and clinical care networks in the world. With nine fully affiliated hospitals and research institutes and 18 community-affiliated hospitals and clinical care sites, the Faculty of Medicine is a research powerhouse that offers unparalleled opportunities for its 6,800 faculty and 8,000-plus students at all levels. Nearly half of Ontario's medical doctors and fully 25 per cent of all health and biomedical PhDs in Canada were trained by the Faculty of Medicine, which consistently ranks among the top medical schools worldwide.

Contacts:
Lindsay Gulin
MS Society of Canada
416-922-6600 x3245
[email protected]

Isabelle Lavigne
Centre hospitalier de l'Universite de Montreal (CHUM)
514-890-8000 x15380
[email protected]

Anita Kar
Montreal Neurological Institute and Hospital
(The Neuro)
514-398-3376
[email protected]

Suniya Kukaswadia
Faculty of Medicine, University of Toronto
416-978-7752
[email protected]

More Stories By Marketwired .

Copyright © 2009 Marketwired. All rights reserved. All the news releases provided by Marketwired are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials is strictly forbidden, including but not limited to, posting, emailing, faxing, archiving in a public database, redistributing via a computer network or in a printed form.

Latest Stories
SYS-CON Events announced today that CollabNet, a global leader in enterprise software development, release automation and DevOps solutions, will be a Bronze Sponsor of SYS-CON's 20th International Cloud Expo®, taking place from June 6-8, 2017, at the Javits Center in New York City, NY. CollabNet offers a broad range of solutions with the mission of helping modern organizations deliver quality software at speed. The company’s latest innovation, the DevOps Lifecycle Manager (DLM), supports Value S...
As DevOps methodologies expand their reach across the enterprise, organizations face the daunting challenge of adapting related cloud strategies to ensure optimal alignment, from managing complexity to ensuring proper governance. How can culture, automation, legacy apps and even budget be reexamined to enable this ongoing shift within the modern software factory?
The 21st International Cloud Expo has announced that its Call for Papers is open. Cloud Expo, to be held October 31 - November 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA, brings together Cloud Computing, Big Data, Internet of Things, DevOps, Digital Transformation, Machine Learning and WebRTC to one location. With cloud computing driving a higher percentage of enterprise IT budgets every year, it becomes increasingly important to plant your flag in this fast-expanding busin...
SYS-CON Events announced today that Hitachi Data Systems, a wholly owned subsidiary of Hitachi LTD., will exhibit at SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City. Hitachi Data Systems (HDS) will be featuring the Hitachi Content Platform (HCP) portfolio. This is the industry’s only offering that allows organizations to bring together object storage, file sync and share, cloud storage gateways, and sophisticated search and...
SYS-CON Events announced today that Progress, a global leader in application development, has been named “Bronze Sponsor” of SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. Enterprises today are rapidly adopting the cloud, while continuing to retain business-critical/sensitive data inside the firewall. This is creating two separate data silos – one inside the firewall and the other outside the firewall. Cloud ISVs oft...
SYS-CON Events announced today that delaPlex will exhibit at SYS-CON's @CloudExpo, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. delaPlex pioneered Software Development as a Service (SDaaS), which provides scalable resources to build, test, and deploy software. It’s a fast and more reliable way to develop a new product or expand your in-house team.
SYS-CON Events announced today that Peak 10, Inc., a national IT infrastructure and cloud services provider, will exhibit at SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. Peak 10 provides reliable, tailored data center and network services, cloud and managed services. Its solutions are designed to scale and adapt to customers’ changing business needs, enabling them to lower costs, improve performance and focus intern...
SYS-CON Events announced today that Juniper Networks (NYSE: JNPR), an industry leader in automated, scalable and secure networks, will exhibit at SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. Juniper Networks challenges the status quo with products, solutions and services that transform the economics of networking. The company co-innovates with customers and partners to deliver automated, scalable and secure network...
SYS-CON Events announced today that Cloud Academy will exhibit at SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. Cloud Academy is the industry’s most innovative, vendor-neutral cloud technology training platform. Cloud Academy provides continuous learning solutions for individuals and enterprise teams for Amazon Web Services, Microsoft Azure, Google Cloud Platform, and the most popular cloud computing technologies. Ge...
Existing Big Data solutions are mainly focused on the discovery and analysis of data. The solutions are scalable and highly available but tedious when swapping in and swapping out occurs in disarray and thrashing takes place. The resolution for thrashing through machine learning algorithms and support nomenclature is through simple techniques. Organizations that have been collecting large customer data are increasingly seeing the need to use the data for swapping in and out and thrashing occurs ...
DevOps is often described as a combination of technology and culture. Without both, DevOps isn't complete. However, applying the culture to outdated technology is a recipe for disaster; as response times grow and connections between teams are delayed by technology, the culture will die. A Nutanix Enterprise Cloud has many benefits that provide the needed base for a true DevOps paradigm.
SYS-CON Events announced today that Interoute has been named “Bronze Sponsor” of SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. Interoute is the owner operator of Europe's largest network and a global cloud services platform, which encompasses over 70,000 km of lit fiber, 15 data centers, 17 virtual data centers and 33 colocation centers, with connections to 195 additional partner data centers. Our full-service Unifie...
SYS-CON Events announced today that Fusion, a leading provider of cloud services, will exhibit at SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. Fusion, a leading provider of integrated cloud solutions to small, medium and large businesses, is the industry’s single source for the cloud. Fusion’s advanced, proprietary cloud service platform enables the integration of leading edge solutions in the cloud, including cloud...
SYS-CON Events announced today that WineSOFT will exhibit at SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. Based in Seoul and Irvine, WineSOFT is an innovative software house focusing on internet infrastructure solutions. The venture started as a bootstrap start-up in 2010 by focusing on making the internet faster and more powerful. WineSOFT’s knowledge is based on the expertise of TCP/IP, VPN, SSL, peer-to-peer, mob...
Detecting internal user threats in the Big Data eco-system is challenging and cumbersome. Many organizations monitor internal usage of the Big Data eco-system using a set of alerts. This is not a scalable process given the increase in the number of alerts with the accelerating growth in data volume and user base. Organizations are increasingly leveraging machine learning to monitor only those data elements that are sensitive and critical, autonomously establish monitoring policies, and to detect...